MODALTIN (U.S. Trademark Serial Number 88196892) is a United States trademark of Tonix Pharmaceuticals, Inc.. The goods and services include: Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders . The correspondent is Francis J. Duffin of WIGGIN AND DANA LLP.

This trademark was filed on November 16, 2018 as United States Trademark Application Serial Number 88196892. This trademark application is still pending and does not yet have a registration number.

Trademark PTO Status History

July 04, 2022 – ABANDONMENT – NO USE STATEMENT FILED

February 19, 2022 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

February 18, 2022 – SOU EXTENSION 5 GRANTED

November 28, 2021 – SOU EXTENSION 5 FILED

February 08, 2022 – CASE ASSIGNED TO INTENT TO USE PARALEGAL

January 05, 2022 – NOTICE OF REVIVAL – E-MAILED

January 05, 2022 – EXTENSION RECEIVED WITH TEAS PETITION

January 05, 2022 – PETITION TO REVIVE-GRANTED

View full trademark status information at USPTO

Ownership History

Tonix Pharmaceuticals, Inc.

Tonix Pharmaceuticals, Inc.

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.